InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Scholtes Bret, Chairman & CEO. Insider active across 2 companies, notably Guardion Health Sciences, Inc.. Aggregated, 5 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €10k. History available since 30 August 2021. The latest transaction was disclosed on 6 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Bret Scholtes is the CEO and President of Guardion Health Sciences, Inc. As CEO, he is responsible for the strategic direction of the company, overseeing operations and growth initiatives. His leadership is essential for the organization's success.